N-acetylcysteine for the treatment of COVID-19 among hospitalized patients

被引：20

作者：

Avdeev, Sergey N. ^{[1
]}

Gaynitdinova, Viliya V. ^{[1
]}

Merzhoeva, Zamira M. ^{[1
]}

Berikkhanov, Zelimkhan G. -M. ^{[1
]}

机构：

[1] Sechenov Univ, IM Sechenov First Moscow State Med Univ, Dept Pulmonol, Moscow, Russia

来源：

JOURNAL OF INFECTION | 2022年 / 84卷 / 01期

关键词：

D O I：

10.1016/j.jinf.2021.07.003

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：99 / 101

页数：3

共 10 条

[1] Application of methylene blue -vitamin C -N-acetyl cysteine for treatment of critically ill COVID-19 patients, report of a phase-I clinical trial [J].

Alamdari, Daryoush Hamidi ;

Moghaddam, Ahmad Bagheri ;

Amini, Shahram ;

Keramati, Mohammad Reza ;

Zarmehri, Azam Moradi ;

Alamdari, Aida Hamidi ;

Damsaz, Mohammadamin ;

Banpour, Hamed ;

Yarahmadi, Amir ;

Koliakos, George .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2020, 885

[2] N-Acetylcysteine as an antioxidant and disulphide breaking agent: the reasons why [J].

Aldini, Giancarlo ;

Altomare, Alessandra ;

Baron, Giovanna ;

Vistoli, Giulio ;

Carini, Marina ;

Borsani, Luisa ;

Sergio, Francesco .

FREE RADICAL RESEARCH, 2018, 52 (07) :751-762

[3] N-Acetylcysteine and Hydrogen Sulfide in Coronavirus Disease 2019 [J].

Bourgonje, Arno R. ;

Offringa, Annette K. ;

van Eijk, Larissa E. ;

Abdulle, Amaal E. ;

Hillebrands, Jan-Luuk ;

van der Voort, Peter H. J. ;

van Goor, Harry ;

van Hezik, Ed J. .

ANTIOXIDANTS & REDOX SIGNALING, 2021, 35 (14) :1207-1225

[4] Double-blind, Randomized, Placebo-controlled Trial With N-acetylcysteine for Treatment of Severe Acute Respiratory Syndrome Caused by Coronavirus Disease 2019 (COVID-19) [J].

Garcia de Alencar, Julio Cesar ;

Moreira, Claudia de Lucena ;

Muller, Alicia Dudy ;

Chaves, Cleuber Esteves ;

Fukuhara, Marina Akemi ;

da Silva, Elizabeth Aparecida ;

Silva Miyamoto, Maria de Fatima ;

Pinto, Vanusa Barbosa ;

Bueno, Caue Gasparotto ;

Lazar Neto, Felippe ;

Gomez, Luz Marina Gomez ;

Saad Menezes, Maria Clara ;

Meirelles Marchini, Julio Flavio ;

Marino, Lucas Oliveira ;

Brandao Neto, Rodrigo Antonio ;

Souza, Heraldo Possolo .

CLINICAL INFECTIOUS DISEASES, 2021, 72 (11) :E736-E741

[5]

Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]

[6]

Horby PW, 2021, LANCET, V397, P1637, DOI 10.1016/S0140-6736(21)00676-0

[7] Therapeutic blockade of inflammation in severe COVID-19 infection with intravenous N-acetylcysteine [J].

Ibrahim, Homam ;

Perl, Andras ;

Smith, Deane ;

Lewis, Tyler ;

Kon, Zachary ;

Goldenberg, Ronald ;

Yarta, Kinan ;

Staniloae, Cezar ;

Williams, Mathew .

CLINICAL IMMUNOLOGY, 2020, 219

[8] INTRAVENOUS N-ACETYLCYSTEINE AND LUNG GLUTATHIONE OF PATIENTS WITH PULMONARY FIBROSIS AND NORMALS [J].

MEYER, A ;

BUHL, R ;

KAMPF, S ;

MAGNUSSEN, H .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (03) :1055-1060

[9]

O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI [10.1086/344188, 10.1086/502007]

[10] SERUM HYDROGEN SULFIDE AND OUTCOME ASSOCIATION IN PNEUMONIA BY THE SARS-COV-2 CORONAVIRUS [J].

Renieris, Georgios ;

Katrini, Konstantina ;

Damoulari, Christina ;

Akinosoglou, Karolina ;

Psarrakis, Christos ;

Kyriakopoulou, Magdalini ;

Dimopoulos, George ;

Lada, Malvina ;

Koufargyris, Panagiotis ;

Giamarellos-Bourboulis, Evangelos J. .

SHOCK, 2020, 54 (05) :633-637

← 1 →